Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
基本信息
- 批准号:10556420
- 负责人:
- 金额:$ 34.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-15 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAffectAgeAgingAngiogenic FactorAnkleApoptosisAttenuatedBlood VesselsBone MarrowBone Marrow CellsBone ResorptionBone TissueCartilageCell AgingCell Cycle ArrestCell ProliferationCellsChronicChronic DiseaseClinical ResearchDecelerationDegenerative polyarthritisDeteriorationDevelopmentDiagnosticDiseaseElderlyFrail ElderlyFunctional disorderGenesGeneticGoalsHand OsteoarthritisHigh Fat DietHip OsteoarthritisHumanInvadedJointsKnee OsteoarthritisKnee jointMeasuresMechanicsMetabolicMetabolic syndromeMononuclearMusMusculoskeletal DiseasesNuclearObesityOsteoclastsOsteogenesisPathogenesisPathogenicityPhenotypePhysiologic OssificationPopulationPrevalenceReporterRisk FactorsRoleSkeletonSynovial MembraneTestingTissuesTransgenic OrganismsTraumatic ArthropathyTubeVascular Endothelial CellWorkage relatedangiogenesisarthropathiesarticular cartilagebone cellcell typedefined contributiondriving forceepidemiology studyfrailtyfunctional lossgenetic approachjoint destructionjoint injurymetabolic phenotypemouse modelnovelosteoarthritis painoverexpressionparticipant enrollmentpharmacologicplatelet-derived growth factor BBradiological imagingsenescencesubchondral bonetreatment strategy
项目摘要
SUMMARY/ABSTRACT
Osteoarthritis (OA) is the most prevalent age-associated chronic joint disease. Although direct joint injury and
excessive mechanical overloading are considered as important contributors to the development of OA, only
approximately 12% of the overall prevalence of symptomatic OA is attributable to posttraumatic OA of the hip,
knee, or ankle. Aging is recognized as the most important risk factor for OA, and the metabolic phenotype
becomes the second most frequent subtype of OA among patients enrolled in clinical studies. Recently, it has
been recognized that cellular senescence is a key driver for the progression of post-traumatic OA. However,
whether and how senescent cells (SnCs) are involved in the development of non-traumatic OA remain poorly
understood. In our preliminary study, we found accumulated SnCs at the joint subchondral bone marrow of both
spontaneous aging OA mice and STR/Ort mice, a spontaneous OA mice associated with metabolic dysregulation.
Increased SnCs were not detected in subchondral bone marrow of a post-traumatic OA mice. Therefore,
subchondral bone marrow cell senescence may represent a unique feature of non-traumatic subtype of OA
distinguishable from post-traumatic OA. Moreover, we identified that close to 80% of the SnCs are bone marrow
Pre-osteoclast (Pre-OC). Pre-OCs isolated from old mice, relative to young mice, had increased expression of
common senescence-associated secretory phenotype (SASP) factors and much higher expression of
angiogenesis factor PDGF-BB, a potent angiogenesis factor. It is known that increased subchondral bone
angiogenesis is a major contributor to the development of OA. Therefore, the excessive PDGF-BB secreted by
subchondral bone marrow SnCs may contribute to aberrant subchondral bone angiogenesis. Our central
hypothesis is that senescent Pre-OCs induce aberrant subchondral bone angiogenesis by secreting excessive
PDGF-BB, leading to OA-related joint structural damage. The hypothesis will be tested by the following Specific
Aims. In Aim 1, we will trace the SnCs in synovial tissue, articular cartilage, and subchondral bone tissue of the
joints by detecting the cellular senescence markers in spontaneous aging OA mice and STR/Ort mice. We will
also trace the SnCs at different stages of OC lineage and verify the SASP phenotype of the cells in bone marrow
of the mice. Aim 2 will examine the necessity and sufficiency of Pre-OCs-derived PDGF-BB in age-associated
subchondral bone angiogenesis and OA development. In Aim 3, we will first define the contribution of cellular
senescence to subchondral bone angiogenesis and osteogenesis by selectively eliminating the SnCs in OA mice.
We will then test if blockage of Pre-OC senescence using both genetic and pharmacologic approaches
attenuates OA progression.
摘要/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mei Wan其他文献
Mei Wan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mei Wan', 18)}}的其他基金
Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
- 批准号:
10090198 - 财政年份:2021
- 资助金额:
$ 34.97万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10544756 - 财政年份:2021
- 资助金额:
$ 34.97万 - 项目类别:
Senescence of Pre-Osteoclasts in Non-Traumatic OA
非创伤性骨关节炎中前破骨细胞的衰老
- 批准号:
10326804 - 财政年份:2021
- 资助金额:
$ 34.97万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10380873 - 财政年份:2021
- 资助金额:
$ 34.97万 - 项目类别:
Identifying A Skeleton-Derived Factor for Vascular Aging
识别血管老化的骨骼衍生因子
- 批准号:
10202909 - 财政年份:2021
- 资助金额:
$ 34.97万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10417206 - 财政年份:2020
- 资助金额:
$ 34.97万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10634546 - 财政年份:2020
- 资助金额:
$ 34.97万 - 项目类别:
Targeting aging genes and pathways to promote optic nerve regeneration
针对衰老基因和途径促进视神经再生
- 批准号:
10547815 - 财政年份:2020
- 资助金额:
$ 34.97万 - 项目类别:
Targeting aging genes and pathways to promote optic nerve regeneration
针对衰老基因和途径促进视神经再生
- 批准号:
10326837 - 财政年份:2020
- 资助金额:
$ 34.97万 - 项目类别:
Role of Cellular Senescence in the Bone-Brain Interplay
细胞衰老在骨脑相互作用中的作用
- 批准号:
10041954 - 财政年份:2020
- 资助金额:
$ 34.97万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 34.97万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 34.97万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 34.97万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 34.97万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 34.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 34.97万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 34.97万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 34.97万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 34.97万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 34.97万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




